REPLY

Sir,
It is a matter of satisfaction that our article has generated interest. We would like to respond to each of the observations by Agarwal (2000) one by one.
(1) We are in complete agreement with the author of this ' letter to editor' that the usage of term non-parametric and parametric variables is not technically sound. However, the conventional usage of these terms is seen in many scientific communications. Certainly, the term 'inappropriate distribution' should best be avoided. (2) We agree that variables with large standard deviation (S.D.) should preferably be analyzed by non-parametric tests. The variables with large S.D. were subjected to re-analysis by Mann Whitney U Test and results obtained were identical to that obtained by t-test. However, it should be mentioned here that, in the original analysis, modified t-test was applied so as to take care of the large S.D. (3) Regression analysis was, indeed, not carried out due to small sample size. In statistical terms, the term predictor' is not in keeping with the analysis so carried out. However, in keeping with previous literature and for want of a better term, 'predictor 1 was used in the research report. (4) Randomized controlled trials on large sample size and with a sound methodology should be an 'idea" method of determining predictors of response to ECT. However, numerous ECT -related and clinical parameters, along with associated ethical issues, need to be taken into consideration at the same time.
This study, being one of the few studies on ECT in depression in India, provides a base on which future research (related to predictors of response to ECT in depression) can be executed.
AJIT AVASTHI.MD, Additional Professor of Psychiatry, PGIMER, Chandigarh -160 012
MODIFIED VERSUS UNMODIFIED ECT : IS THERE A PARADIGM SHIFT?
Sir,
There has been a resurgence of interest in the ongoing debate between the use of modified versus unmodified ECT with respect to Indian population. The earlier recommendation of mandatory use of modified ECT as expressed in the aftermath of the National Conference on ECT in 1990 has now been questioned (Shah and Rassiwala,2000) . In a similar vein, unmodified ECT has recently been shown to have considerably less musculoskeletal morbidity then earlier believed (Andrade et al.,2000) . Thus, there appears an emerging consensus that while modified ECT is desirable where adequate facilities are available, < unmodified ECT cannot be looked down with abhorrence and totally discarded. Similar views have been expressed by many authors in a recent issue of Archives of Indian Psychiatry devoted entirely to ECT (Agarwal,2000; Nambi, 2000; Trivedi and Mahendru,2000) This represents a paradigm shift from that recommending only modified ECT to choosing between modified and unmodified ECT based on the availability of anesthesiologists and the requisite infrastructure. The practical guidelines for the clinical use of ECT provided by the Bombay Psychiatric Society (Gada et al. ,2000) represent a step in this direction and is a laudable effort. The Indian Psychiatric Society (IPS) may consider these guidelines while framing its own guidelines for the practice of ECT in India.
Concern has been raised on the recent High Court of Bombay ruling which stated that ECT without anesthesia was inhuman (Channabasavanna et al., 2000) . Based on this the same authors have suggested the use of only modified ECT in clinical practice as patients may claim compensation for increasing the risk of complications while using unmodified ECT. However, the article by Andrade et al. (2000) provides new insights into the fact that unmodified ECT may have lesser complications than previously thought Hence, it is desirable that IPS frame guidelines, which consider both modified and unmodified ECT so that the psychiatrists practicing either modality of ECT in our country can be appropriately guided in legal issues.
FLUOXETINE AND PARESTHESIAS
Sir, Paresthesia associated with selective serotonin reuptake inhibitor (SSRI) therapy is rare, and has been described both as an adverse effect of SSRI drugs (Masand and Gupta, 1999) and in part of the SSR'I withdrawal syndrome (Black et al., 2000) in Caucasian subjects. Since ethnic issues in psychopharmacology are an important matter, and since no case of paresthesia associated with SSRIs has so far been reported from the Indian subcontinent, we wish to place the following case on record, CASEREPORT Mrs. S, a 36-year-old woman, was prescribed fluoxetine (20 mg/day) for a DSM-IV diagnosis of adjustment disorder with depressed mood. A week later, she began to experience tingling sensations in the left foot. These paresthesias increased over the following weeks and spread to the entire lower limb and the left upper limb as well.
Physical examination, hematocrit, blood glucose, serum electrolytes, thyroid function tests, spinal X-rays, and other investigations were a" within normal limits. She was antinuclear antibody negative. Medical, neurological, and orthopedic consultations ruled out identifiable disease. Fluoxetine was discontinued with the hypothesis that her symptoms were drug-related. There was a decrease in the intensity of the paresthesias.
Withdrawal of fluoxetine, however, led to a worsening of mood. Fluoxetine was re-introduced. Resumption of the drug resulted in worsening of
